Skip to main content
. 2021 Jun 25;87(14):e00480-21. doi: 10.1128/AEM.00480-21

TABLE 2.

Synthetic oligonucleotides used in this study

Primer name 5′→3′ sequence Purpose
actII-ORF4 F AAAGGAATATCGCGCACCTGGAAG qPCR
actII-ORF4 R GTTCCGGAATCATCGGCCCTATTC qPCR
hrdB F GCATGCTCTTCCTGGACCTCAT qPCR
hrdB R TGGAGAACTTGTAGCCCTTGGTGTA qPCR
hmpA F AACAGTCCGTTCCCGTGGT qPCR
hmpA R CGAAGAGCTTGCGGTAGAACAG qPCR
devR F ACGACGAACCGGACATCACC qPCR
devR R CGTCGTCGAAGGAGGTCAGC qPCR
actII-ORF4 promoter region F GGACCCAGCCGTATCAGGAA qPCR and EMSA
actII-ORF4 promoter region R GTCTCCTGGGGGGCGACAATA qPCR and EMSA
comp devR/S F GAATTCCGAGGACGCGCCGTGGAGG Complementation
comp devR/S R AAGCTTCGGACCGGCCGCCTTCC Complementation
comp devR-FLAG F GAATTCCGAGGACGCCGTCGACG Complementation
comp devR-FLAG R AAGCTTTCACTTGTCATCGTCATCCTTGTAATCGATGTCATGATCTTTATAATCTCCGTCATGGTCTTTGTAGTCGGTTCTGGCCTTCGGTGCGCATC Complementation
ΔwblA F TGGGGGAGCCTCGATTCGGGAGAGGACGGCGCCGGTATGATTCCGGGGATCCGTCGACC Disruption
ΔwblA R GGCGCCTGATCCGGGCCCCTGGTCCGGCCTCGGGGCTCATATAGGCTGGAGCTGCTTC Disruption